Literature DB >> 16225801

Shifting epidemiology of Flaviviridae.

Lyle R Petersen1, Anthony A Marfin.   

Abstract

The dengue, West Nile, Japanese encephalitis and yellow fever viruses are important mosquito-borne viruses whose epidemiology is shifting in response to changing societal factors, such as increasing commerce, urbanization of rural areas, and population growth. All four viruses are expanding geographically, as exemplified by the emergence of West Nile virus in the Americas and Japanese encephalitis virus in Australasia. The large, recent global outbreaks of severe neurological disease caused by West Nile virus, the increasing frequency of dengue hemorrhagic fever outbreaks in the Americas, and the emergence of yellow fever virus vaccination-associated viscerotropic disease, are new clinical epidemiologic trends. These worrisome epidemiologic trends will probably continue in coming decades, as a reversal of their societal and biological drivers is not in sight. Nevertheless, the substantial reductions in Japanese encephalitis virus incidence resulting from vaccination programs and economic development in some Asian countries provide some encouragement within this overall guarded outlook.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225801     DOI: 10.2310/7060.2005.12052

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  15 in total

Review 1.  Travel medicine for the extreme traveler.

Authors:  David R Boulware
Journal:  Dis Mon       Date:  2006-08       Impact factor: 3.800

2.  Generation of a Lineage II Powassan Virus (Deer Tick Virus) cDNA Clone: Assessment of Flaviviral Genetic Determinants of Tick and Mosquito Vector Competence.

Authors:  Joan L Kenney; Michael Anishchenko; Meghan Hermance; Hannah Romo; Ching-I Chen; Saravanan Thangamani; Aaron C Brault
Journal:  Vector Borne Zoonotic Dis       Date:  2018-05-21       Impact factor: 2.133

3.  Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.

Authors:  Yoko Kitai; Mizue Shoda; Takashi Kondo; Eiji Konishi
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

4.  TRAIL is a novel antiviral protein against dengue virus.

Authors:  Rajas V Warke; Katherine J Martin; Kris Giaya; Sunil K Shaw; Alan L Rothman; Irene Bosch
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 5.  Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.

Authors:  Carlo Amorin Daep; Jorge L Muñoz-Jordán; Eliseo Alberto Eugenin
Journal:  J Neurovirol       Date:  2014-10-07       Impact factor: 2.643

6.  Activity of T-1106 in a hamster model of yellow Fever virus infection.

Authors:  Justin G Julander; Yousuke Furuta; Kristiina Shafer; Robert W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

7.  Demographic and clinical features of dengue fever in Pakistan from 2003-2007: a retrospective cross-sectional study.

Authors:  Erum Khan; Mehreen Kisat; Nabil Khan; Amna Nasir; Salma Ayub; Rumina Hasan
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

8.  Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus.

Authors:  Charles E McGee; Konstantin A Tsetsarkin; Bruno Guy; Jean Lang; Kenneth Plante; Dana L Vanlandingham; Stephen Higgs
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

9.  TNF-α promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis.

Authors:  Sujit Kumar Pujhari; Radha Kanta Ratho; Sudesh Prabhakar; Baijayantimala Mishra; Manish Modi
Journal:  BMC Infect Dis       Date:  2012-01-26       Impact factor: 3.090

Review 10.  Flavivirus-mosquito interactions.

Authors:  Yan-Jang S Huang; Stephen Higgs; Kate McElroy Horne; Dana L Vanlandingham
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.